Stock Technicians Like the Bullish Support for These Healthcare Stocks Now

Following is a list of 10 companies in the Healthcare sector whose stock are trading above their 50-day moving average.  Criteria for this screen are:

  • The shares trade on an American exchange.
  • Market capitalization is at least $1 billion.
  • The sector in which the company operates is Healthcare.  The Healthcare sector includes all companies that operate in the following industries: Healthcare Equipment & Supplies, Healthcare Providers & Services, Pharmaceuticals, and Biotechnology & Medical Research.

Our screen returned 29 companies in this sector.  The 10 that follow have the highest percentage price change of their 50-day moving average.  As should be expected for momentum trades of this type, the stock trading the highest above their 50-day moving average tend to be relatively smaller companies.

  • Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): This company has a market capitalization of $1,445,334,000. The stock last traded at $10.95, which is 22.76% above its 50-day moving average. About the company:  ARIAD Pharmaceuticals, Inc. discovers, develops, and commercializes small-molecule drugs to treat aggressive cancers. The Company’s first product candidate is an investigational mTOR inhibitor. ARIAD’s second product candidate is an investigational pan BCR-ABL inhibitor for treatment of blood cancers.
  • Elan Corporation, plc (ADR) (NYSE:ELN): This company has a market capitalization of $6,412,198,000. The stock last traded at $10.85, which is 19.50% above its 50-day moving average. About the company:  Elan Corporation plc is a specialty pharmaceutical company. The Group’s drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan’s Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.
  • Seattle Genetics, Inc. (NASDAQ:SGEN): This company has a market capitalization of $2,338,104,000. The stock last traded at $20.55, which is 12.65% above its 50-day moving average. About the company:  Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company’s technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
  • Acorda Therapeutics Inc. (NASDAQ:ACOR): This company has a market capitalization of $1,279,358,000. The stock last traded at $32.42, which is 10.26% above its 50-day moving average. About the company:  Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
  • Forest Laboratories, Inc. (NYSE:FRX): This company has a market capitalization of $11,246,190,000. The stock last traded at $39.30, which is 9.95% above its 50-day moving average. About the company:  Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe.
  • Biogen Idec Inc. (NASDAQ:BIIB): This company has a market capitalization of $25,286,810,000. The stock last traded at $104.65, which is 9.53% above its 50-day moving average. About the company:  Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR): This company has a market capitalization of $1,461,704,000. The stock last traded at $23.70, which is 9.10% above its 50-day moving average. About the company:  Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company’s primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
  • Alkermes, Inc. (NASDAQ:ALKS): This company has a market capitalization of $1,701,157,000. The stock last traded at $17.77, which is 7.91% above its 50-day moving average. About the company:  Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.
  • Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): This company has a market capitalization of $1,311,071,000. The stock last traded at $32.18, which is 7.73% above its 50-day moving average. About the company:  Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.
  • Volcano Corporation (NASDAQ:VOLC): This company has a market capitalization of $1,591,904,000. The stock last traded at $30.53, which is 7.40% above its 50-day moving average. About the company:  Volcano Corporation develops, manufactures, and commercializes medical devices. The Company’s products include intravascular ultrasound (IVUS) catheters and Functional Measurement guide wires used to diagnose and assess diseases of the coronary and peripheral vasculature.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>